Deep Isolation Nuclear Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	6.06	6.14	7.05	5.38
Revenue Growth (YoY)	-12.59%	-13.00%	31.22%	-
Cost of Revenue	2.65	2.63	3.67	3.07
Gross Profit	3.41	3.5	3.39	2.31
Selling, General & Admin	10.6	8.75	4.14	5.38
Research & Development	3.89	0.4	0.2	-
Operating Expenses	14.6	9.27	4.45	5.49
Operating Income	-11.19	-5.77	-1.07	-3.18
Other Non Operating Income (Expenses)	0.61	0.44	0.07	0
EBT Excluding Unusual Items	-10.59	-5.34	-0.99	-3.18
Other Unusual Items	-	-	-	-0.38
Pretax Income	-10.59	-5.34	-0.99	-3.56
Income Tax Expense	-	0	0	0
Net Income	-10.59	-5.34	-0.99	-3.56
Net Income to Common	-10.59	-5.34	-0.99	-3.56
Shares Outstanding (Basic)	58	49	40	1
Shares Outstanding (Diluted)	58	49	40	1
Shares Change (YoY)	-	22.20%	5158.99%	-
EPS (Basic)	-0.18	-0.11	-0.02	-4.69
EPS (Diluted)	-0.18	-0.11	-0.02	-4.69
Free Cash Flow	-9.28	-4.04	-1.2	-2.4
Free Cash Flow Per Share	-0.16	-0.08	-0.03	-3.17
Gross Margin	56.24%	57.07%	48.04%	42.92%
Operating Margin	-184.63%	-94.03%	-15.11%	-59.14%
Profit Margin	-174.60%	-86.96%	-14.09%	-66.16%
Free Cash Flow Margin	-152.99%	-65.78%	-17.03%	-44.71%
EBITDA	-11.08	-5.66	-0.96	-3.08
EBITDA Margin	-182.80%	-92.16%	-13.55%	-57.21%
D&A For EBITDA	0.11	0.12	0.11	0.1
EBIT	-11.19	-5.77	-1.07	-3.18
EBIT Margin	-184.63%	-94.03%	-15.11%	-59.14%